Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Nassim, Omid M.D.
WARNING LETTER
•Nassim, Omid M.D.•December 5, 2012

Nassim, Omid M.D. – FDA Warning Letter, Dec 5, 2012

Record Details

The FDA issued a Warning Letter to Omid Nassim, M.D., of Alia Clinical Research, Inc., following an inspection conducted between October 12 and December 5, 2012. The inspection reviewed clinical investigations of the investigational drug BI 10773 (empagliflozin) for Boehringer Ingelheim Pharmaceuticals (Protocols 1245.23 and 1245.25). The FDA concluded that Dr. Nassim did not adhere to applicable statutory requirements and FDA regulations governing clinical investigations. Two main violations were identified: 1) Failure to ensure the investigation was conducted according to the investigational plan (21 CFR 312.60), specifically enrolling five subjects into Protocol 1245.25 who did not meet the high cardiovascular risk inclusion criteria, which jeopardized subject safety and data integrity. 2) Failure to obtain Institutional Review Board (IRB) approval for changes in the research prior to implementing them (21 CFR 312.66), as Protocol 1245.25, Revision 3 (Version 4) with significant inclusion criteria changes was implemented before IRB approval. Dr. Nassim's December 24, 2012, response to the Form FDA 483 was deemed inadequate, lacking sufficient detail on corrective action plans and evidence of IRB approval. The FDA requires a written response within fifteen working days detailing actions taken to prevent future violations, warning that failure to address these deficiencies adequately and promptly may result in further regulatory action.

Company
Nassim, Omid M.D.
Inspection date
December 5, 2012
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas N. Moreno
View Company Profile

ID · 114862c0-7df9-4a33-85e0-8c6ba2fb82f2

Violation Codes2
21 CFR 312.6021 CFR 312.66

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nassim, Omid M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.